Dublin-based biotech outfit Inflazome has been acquired for €380 million by Swiss drug company Roche

📆 21/9/2563 22:35:00
📰 thejournal_ie

⏱ Reading Time:
26 sec. here
2 min. at publisher
📊 Quality Score:
News: 14%
Publisher: 50%

ประเทศไทย ข่าว ข่าว

ประเทศไทย ข่าวล่าสุด,ประเทศไทย หัวข้อข่าว

The acquisition gives Roche access to Inflazome's entire portfolio, which includes drugs that are currently in trials as well as earlier-stage programmes.

Image: Shutterstock/anyaivanova Image: Shutterstock/anyaivanova IRISH BIOTECH COMPANY Inflazome has been acquired by Swiss drug giant Roche for €380 million.

It is understood that they are also eligible to receive additional payments contingent on the achievement of certain milestones. Speaking on the Pat Kenny Show on Newstalk this morning, Professor O’Neill said, “Roche can now take our drug and bring it to the clinic, which is tremendously exciting. Founded in 2016, the company’s intellectual property is based on the Science Foundation Ireland-funded research of Professor O’Neill at Trinity College Dublin in partnership with the University of Queensland.

เขียนความคิดเห็น

เราได้สรุปข่าวนี้มาให้อ่านอย่างรวดเร็ว หากสนใจข่าว สามารถอ่านฉบับเต็มได้ที่นี่ อ่านเพิ่มเติม:

ประเทศไทย ข่าวล่าสุด, ประเทศไทย หัวข้อข่าว